Albert Manero, President of Limbitless Solutions, describes the groundbreaking work he and his team are doing in the fields of prosthetics and bionics, work that includes a brush with fame in the form of a certain Marvel superhero.
Columbia University researchers recently generated beating cardiac tissue from induced pluripotent stem cells, human cells that are able to differentiate into nearly any cell type. Using physical conditioning, the researchers produced samples with the hallmarks of mature heart tissue with just four weeks of cell culture. The work paves a concrete pathway to functional heart-on-a-chip platforms.
Biomedical engineers at Texas A&M University developed a hydrogel made from nanoflakes of synthetic clay and sugar chains extracted from seaweed. The gel could act as an injectable bandage to stop internal bleeding on a battlefield, in a surgical suite, or at an accident site.
Cellular Biomedicine Group, a clinical-stage biopharmaceutical company that develops immunotherapies for cancer and stem cell therapies for degenerative diseases, recently partnered with GE Healthcare to build a platform to produce therapies at scale for clinical trials. Aims to solve challenge of developing enough genetically modified cells to test products on large populations.